Cotranscriptional folding of single riboswitches

单个核糖开关的共转录折叠

基本信息

  • 批准号:
    9357619
  • 负责人:
  • 金额:
    $ 30.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-23 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The ultimate goal of this proposal is to unravel the coupling between RNA transcription and folding. It is well known that nascent RNA secondary structure can have a significant impact on transcription, as exemplified by the hairpin that acts as a key component of intrinsic terminators. Furthermore, the time-ordered, directional RNA synthesis that occurs during transcription often yields RNA folds other than the most thermodynamically stable structure of the full-length transcript. This coupling between transcription and functional RNA folding is merely one example in an emerging field that seeks to understand the relationship between gene expression and RNA structure. In an elegant example of this relationship, bacterial riboswitches contain non-coding RNA "aptamers" whose secondary and tertiary structures re-fold in response to binding of a small metabolite, leading to a change in expression of the downstream gene through effects on transcription termination or translation initiation. Riboswitches are a key mechanism of gene regulation in bacteria where, in some species, they are responsible for the regulation of up to 4% of all genes, rendering them excellent model systems with potential for real-world impact as drug targets. The study of riboswitches has so far been divided into two separate areas of inquiry: the structural and biophysical studies of isolated aptamer domains, and in vivo studies of gene regulation using riboswitches incorporated into reporter constructs. While this has led to extensive knowledge of the mechanisms by which aptamers sense their ligands and the discovery of many new regulatory RNA sequences, precious little is still known about riboswitch behavior in the context of the macromolecular complexes that they regulate. We will fill this gap through study of a favorably small riboswitch that regulates the efficiency of transcription termination in response t 7-aminomethyl-7-deazaguanine (preQ1) binding. To do so, we will leverage a unique combination of biophysical and biochemical tools to study the riboswitch in active transcription complexes. We will perform single molecule fluorescence resonance energy transfer (smFRET) measurements on paused transcription complexes consisting of a DNA bubble and a fluorophore-labeled nascent riboswitch transcript bound to RNA polymerase, determining the effects of downstream RNA sequence and polymerase on aptamer structure and dynamics (Specific Aim 1). We will use a technique we recently developed termed Single Molecule Kinetic Analysis of RNA Transient Structure (SiM-KARTS) to probe the relative formation of terminator and antiterminator hairpins in the expression platforms of pre-synthesized as well as actively transcribed RNA, determining the role of co-transcriptional folding in riboswitch function (Specific Aim 2). Finally, we will combine in vitro transcription assays and smFRET to study the termination effects of transcription factors NusA and RfaH, which have been shown to affect nascent RNA structure formation (Specific Aim 3). In addition to advancing our understanding of riboswitches, these studies have the potential to transform our understanding of RNA structure formation in general, and of how RNA structure is coupled to the function of macromolecular machines.
 描述(由申请人提供):该提案的最终目标是阐明 RNA 转录和折叠之间的耦合,众所周知,新生 RNA 二级结构可以对转录产生重大影响,如充当发夹的例子。此外,转录过程中发生的按时间顺序定向的 RNA 合成通常会产生除全长转录物热力学最稳定的结构之外的 RNA 折叠。这种转录与功能性 RNA 之间的耦合。折叠只是寻求了解基因表达与 RNA 结构之间关系的新兴领域的一个例子,细菌核糖开关包含非编码 RNA“适体”,其二级和三级结构会相应地重新折叠。核糖开关是细菌基因调控的关键机制,在某些物种中,它们负责向上的调控。到占所有基因的 4%,使它们成为优秀的模型系统,具有作为药物靶点对现实世界产生影响的潜力。迄今为止,核糖开关的研究已分为两个独立的研究领域:分离适体结构域的结构和生物物理学研究,以及核糖开关的研究。使用整合到报告构建体中的核糖开关进行基因调控的体内研究虽然这使得人们对适体感知其配体的机制有了广泛的了解,并发现了许多新的调节RNA序列,但人们对核糖开关在核酸中的行为仍然知之甚少。我们将通过研究一种可调节 7-氨甲基-7-脱氮鸟嘌呤 (preQ1) 结合的转录终止效率的核糖开关来填补这一空白。结合生物物理和生化工具来研究活性转录复合物中的核糖开关我们将对由 DNA 气泡和组成的暂停转录复合物进行单分子荧光共振能量转移 (smFRET) 测量。荧光团标记的新生核糖开关转录物与 RNA 聚合酶结合,确定下游 RNA 序列和聚合酶对适体结构和动力学的影响(具体目标 1)。 SiM-KARTS)探测预合成和活跃转录 RNA 表达平台中终止子和反终止子发夹的相对形成,确定最后,我们将结合体外转录测定和 smFRET 来研究转录因子 NusA 和 RfaH 的终止效应,这些因子已被证明会影响新生 RNA 结构的形成(具体目标 3)。除了增进我们对核糖开关的理解之外,这些研究还有可能改变我们对 RNA 结构形成以及 RNA 结构如何与大分子功能耦合的理解。机器。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NILS G WALTER其他文献

NILS G WALTER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NILS G WALTER', 18)}}的其他基金

The RNA nanomachines of the gene expression machinery dissected at the single molecule level
在单分子水平上剖析基因表达机器的RNA纳米机器
  • 批准号:
    10390477
  • 财政年份:
    2019
  • 资助金额:
    $ 30.37万
  • 项目类别:
The RNA nanomachines of the gene expression machinery dissected at the single molecule level
在单分子水平上剖析基因表达机器的RNA纳米机器
  • 批准号:
    9920170
  • 财政年份:
    2019
  • 资助金额:
    $ 30.37万
  • 项目类别:
Administrative Supplement for a Cytosurge FluidFM OMNIUM instrument: The RNA nanomachines of the gene expression machinery dissected at the single molecule level
Cytosurge FluidFM OMNIUM 仪器的行政补充:在单分子水平上解剖的基因表达机器的 RNA 纳米机器
  • 批准号:
    10797186
  • 财政年份:
    2019
  • 资助金额:
    $ 30.37万
  • 项目类别:
Administrative Supplement for a Turnkey Fluorescence Microscope: Riboswitch mechanism unraveled at the single molecule level
交钥匙荧光显微镜的管理补充:在单分子水平上揭示核糖开关机制
  • 批准号:
    9894327
  • 财政年份:
    2019
  • 资助金额:
    $ 30.37万
  • 项目类别:
The RNA nanomachines of the gene expression machinery dissected at the single molecule level
在单分子水平上剖析基因表达机器的RNA纳米机器
  • 批准号:
    10613420
  • 财政年份:
    2019
  • 资助金额:
    $ 30.37万
  • 项目类别:
Single-molecule counting of cancer biomarker miRNAs in human biofluids
人体生物体液中癌症生物标志物 miRNA 的单分子计数
  • 批准号:
    9233284
  • 财政年份:
    2017
  • 资助金额:
    $ 30.37万
  • 项目类别:
Cotranscriptional folding of single riboswitches
单个核糖开关的共转录折叠
  • 批准号:
    9079585
  • 财政年份:
    2016
  • 资助金额:
    $ 30.37万
  • 项目类别:
HCV biology and inhibition visualized at the single molecule level
HCV 生物学和抑制在单分子水平上可视化
  • 批准号:
    8641463
  • 财政年份:
    2013
  • 资助金额:
    $ 30.37万
  • 项目类别:
HCV biology and inhibition visualized at the single molecule level
HCV 生物学和抑制在单分子水平上可视化
  • 批准号:
    8785654
  • 财政年份:
    2013
  • 资助金额:
    $ 30.37万
  • 项目类别:
Spliceosome Mechanism Dissected at the Single Molecule Level
单分子水平剖析剪接体机制
  • 批准号:
    8415518
  • 财政年份:
    2012
  • 资助金额:
    $ 30.37万
  • 项目类别:

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 30.37万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 30.37万
  • 项目类别:
Vector engineering for non-viral delivery of large genomic DNA to the RPE
用于将大基因组 DNA 非病毒传递至 RPE 的载体工程
  • 批准号:
    10667049
  • 财政年份:
    2023
  • 资助金额:
    $ 30.37万
  • 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
  • 批准号:
    10822502
  • 财政年份:
    2023
  • 资助金额:
    $ 30.37万
  • 项目类别:
Development of a novel site-and cell-selective mRNA therapeutic to treat atherosclerosis
开发一种新的位点和细胞选择性 mRNA 治疗剂来治疗动脉粥样硬化
  • 批准号:
    10679992
  • 财政年份:
    2023
  • 资助金额:
    $ 30.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了